메뉴 건너뛰기




Volumn 3, Issue 2, 2007, Pages 92-95

Quadrivalent human papillomavirus recombinant vaccine: The first vaccine for cervical cancers

Author keywords

Cervical cancers; Quadrivalent human papillomavirus; Recombinant vaccine

Indexed keywords

HEPATITIS B VACCINE; HUMAN PAPILLOMAVIRUS TYPE 16 VIRUS LIKE PARTICLE VACCINE; IMMUNOSUPPRESSIVE AGENT; PLACEBO; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

EID: 34548703619     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.34686     Document Type: Review
Times cited : (14)

References (19)
  • 2
    • 0346787790 scopus 로고    scopus 로고
    • Vaccines against papillomavirus infections and disease
    • Villa LL. Vaccines against papillomavirus infections and disease. Salud Publica Mex 2003;45:S443-8.
    • (2003) Salud Publica Mex , vol.45
    • Villa, L.L.1
  • 5
    • 33748113494 scopus 로고    scopus 로고
    • Fresh from the pipeline: Quadrivalent human papillo-mavirus recombinant vaccine
    • Crum C, Jones C, Kirkpatrick P. Fresh from the pipeline: Quadrivalent human papillo-mavirus recombinant vaccine. Nat Rev Drug Discov 2006;5:629-30.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 629-630
    • Crum, C.1    Jones, C.2    Kirkpatrick, P.3
  • 6
    • 34548663512 scopus 로고    scopus 로고
    • Gardasil® [Quadrivalent Human Papillomavirus (type 6,11,16.18) recombinant vaccine]. Merck and CO, Inc. White House Station: USA; 2006.
    • Gardasil® [Quadrivalent Human Papillomavirus (type 6,11,16.18) recombinant vaccine]. Merck and CO, Inc. White House Station: USA; 2006.
  • 7
    • 17444368112 scopus 로고    scopus 로고
    • The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: Consequences for clinical management
    • Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: Consequences for clinical management. Eur J Gynaecol Oncol 2005;26:129-42.
    • (2005) Eur J Gynaecol Oncol , vol.26 , pp. 129-142
    • Brinkman, J.A.1    Caffrey, A.S.2    Muderspach, L.I.3    Roman, L.D.4    Kast, W.M.5
  • 8
    • 0036559896 scopus 로고    scopus 로고
    • Papillomaviruses and cancer: From basic studies to clinical application
    • zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
    • (2002) Nat Rev Cancer , vol.2 , pp. 342-350
    • zur Hausen, H.1
  • 9
    • 33646421976 scopus 로고    scopus 로고
    • Prophylactic human papillomavirus vaccines
    • Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J Clin Invest 2006;116:1167-73.
    • (2006) J Clin Invest , vol.116 , pp. 1167-1173
    • Lowy, D.R.1    Schiller, J.T.2
  • 11
    • 24644518036 scopus 로고    scopus 로고
    • Vaccines against human papillomavirus and cervical cancer: Promises and Challenges
    • Mahdavi A, Monk BJ. Vaccines against human papillomavirus and cervical cancer: Promises and Challenges. Oncologist 2005;10:528-38.
    • (2005) Oncologist , vol.10 , pp. 528-538
    • Mahdavi, A.1    Monk, B.J.2
  • 12
    • 33747038742 scopus 로고    scopus 로고
    • Human papillomavirus prophylactic vaccines: Stakes and perspectives
    • Hantz S, Alain S, Denis F. Human papillomavirus prophylactic vaccines: Stakes and perspectives. Gynecol Obstet Fertil 2006;34:647-55.
    • (2006) Gynecol Obstet Fertil , vol.34 , pp. 647-655
    • Hantz, S.1    Alain, S.2    Denis, F.3
  • 13
    • 20944448032 scopus 로고    scopus 로고
    • Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
    • Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
  • 15
    • 33644849136 scopus 로고    scopus 로고
    • Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: A randomized controlled trial
    • Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: A randomized controlled trial. Obstet Gynecol 2006;107:18-27.
    • (2006) Obstet Gynecol , vol.107 , pp. 18-27
    • Mao, C.1    Koutsky, L.A.2    Ault, K.A.3    Wheeler, C.M.4    Brown, D.R.5    Wiley, D.J.6
  • 16
    • 33746839247 scopus 로고    scopus 로고
    • Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16 and 18. Vaccine 2006;24:5571-83.
    • Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16 and 18. Vaccine 2006;24:5571-83.
  • 17
    • 33748541969 scopus 로고    scopus 로고
    • HPV vaccines: Now that they.re here, how do we maximize their benefit? Contrception
    • Myers ER. HPV vaccines: Now that they.re here, how do we maximize their benefit? Contrception 2006;74:277-9.
    • (2006) , vol.74 , pp. 277-279
    • Myers, E.R.1
  • 18
    • 34548669345 scopus 로고    scopus 로고
    • Drugs approved by the FDA. Drug Name: Gardasil (quadrivalent human papillomavirus types 6,11,16,18) recombinant vaccine. Center watch newly approved drug therapies listing, Center Watch, Inc: 2006.
    • Drugs approved by the FDA. Drug Name: Gardasil (quadrivalent human papillomavirus types 6,11,16,18) recombinant vaccine. Center watch newly approved drug therapies listing, Center Watch, Inc: 2006.
  • 19
    • 33644979457 scopus 로고    scopus 로고
    • Preventing cervical cancer in the developing world
    • Katz IT, Wright AA. Preventing cervical cancer in the developing world. N Engl J Med 2006;354:1110.
    • (2006) N Engl J Med , vol.354 , pp. 1110
    • Katz, I.T.1    Wright, A.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.